These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 18799829)

  • 1. Feasibility of MRI guided proton therapy: magnetic field dose effects.
    Raaymakers BW; Raaijmakers AJ; Lagendijk JJ
    Phys Med Biol; 2008 Oct; 53(20):5615-22. PubMed ID: 18799829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic-field-induced dose effects in MR-guided radiotherapy systems: dependence on the magnetic field strength.
    Raaijmakers AJ; Raaymakers BW; Lagendijk JJ
    Phys Med Biol; 2008 Feb; 53(4):909-23. PubMed ID: 18263948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.
    Suit H; Kooy H; Trofimov A; Farr J; Munzenrider J; DeLaney T; Loeffler J; Clasie B; Safai S; Paganetti H
    Radiother Oncol; 2008 Feb; 86(2):148-53. PubMed ID: 18237800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An analytical solution to proton Bragg peak deflection in a magnetic field.
    Wolf R; Bortfeld T
    Phys Med Biol; 2012 Sep; 57(17):N329-37. PubMed ID: 22892827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrating a MRI scanner with a 6 MV radiotherapy accelerator: impact of the surface orientation on the entrance and exit dose due to the transverse magnetic field.
    Raaijmakers AJ; Raaymakers BW; van der Meer S; Lagendijk JJ
    Phys Med Biol; 2007 Feb; 52(4):929-39. PubMed ID: 17264362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose optimization for the MRI-accelerator: IMRT in the presence of a magnetic field.
    Raaijmakers AJ; Hårdemark B; Raaymakers BW; Raaijmakers CP; Lagendijk JJ
    Phys Med Biol; 2007 Dec; 52(23):7045-54. PubMed ID: 18029992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modelling carcinogenesis after radiotherapy using Poisson statistics: implications for IMRT, protons and ions.
    Jones B
    J Radiol Prot; 2009 Jun; 29(2A):A143-57. PubMed ID: 19454805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton therapy of uveal melanomas: intercomparison of MRI-based and conventional treatment planning.
    Marnitz S; Cordini D; Bendl R; Lemke AJ; Heufelder J; Simiantonakis I; Kluge H; Bechrakis NE; Foerster MH; Hinkelbein W
    Strahlenther Onkol; 2006 Jul; 182(7):395-9. PubMed ID: 16826358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular PET/CT imaging-guided radiation therapy treatment planning.
    Zaidi H; Vees H; Wissmeyer M
    Acad Radiol; 2009 Sep; 16(9):1108-33. PubMed ID: 19427800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A potential method for in vivo range verification in proton therapy treatment.
    Lu HM
    Phys Med Biol; 2008 Mar; 53(5):1413-24. PubMed ID: 18296770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosimetry for the MRI accelerator: the impact of a magnetic field on the response of a Farmer NE2571 ionization chamber.
    Meijsing I; Raaymakers BW; Raaijmakers AJ; Kok JG; Hogeweg L; Liu B; Lagendijk JJ
    Phys Med Biol; 2009 May; 54(10):2993-3002. PubMed ID: 19387100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI/linac integration.
    Lagendijk JJ; Raaymakers BW; Raaijmakers AJ; Overweg J; Brown KJ; Kerkhof EM; van der Put RW; Hårdemark B; van Vulpen M; van der Heide UA
    Radiother Oncol; 2008 Jan; 86(1):25-9. PubMed ID: 18023488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bio-IGRT - biological image-guided radiotherapy].
    Yaromina A; Zips D
    Nuklearmedizin; 2010; 49 Suppl 1():S50-2. PubMed ID: 21152688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A (short) history of image-guided radiotherapy.
    Verellen D; De Ridder M; Storme G
    Radiother Oncol; 2008 Jan; 86(1):4-13. PubMed ID: 18083259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of an easy-to-handle range measurement tool using a plastic scintillator for proton beam therapy.
    Fukushima Y; Hamada M; Nishio T; Maruyama K
    Phys Med Biol; 2006 Nov; 51(22):5927-36. PubMed ID: 17068374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards MRI-guided linear accelerator control: gating on an MRI accelerator.
    Crijns SP; Kok JG; Lagendijk JJ; Raaymakers BW
    Phys Med Biol; 2011 Aug; 56(15):4815-25. PubMed ID: 21753236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodality image fusion and planning and dose delivery for radiation therapy.
    Saw CB; Chen H; Beatty RE; Wagner H
    Med Dosim; 2008; 33(2):149-55. PubMed ID: 18456166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A point dose method for in vivo range verification in proton therapy.
    Lu HM
    Phys Med Biol; 2008 Dec; 53(23):N415-22. PubMed ID: 18997263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Installation of the 1.5 T MRI accelerator next to clinical accelerators: impact of the fringe field.
    Kok JG; Raaymakers BW; Lagendijk JJ; Overweg J; de Graaff CH; Brown KJ
    Phys Med Biol; 2009 Sep; 54(18):N409-15. PubMed ID: 19687566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental verification of magnetic field dose effects for the MRI-accelerator.
    Raaijmakers AJ; Raaymakers BW; Lagendijk JJ
    Phys Med Biol; 2007 Jul; 52(14):4283-91. PubMed ID: 17664608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.